Indicator,S.No.,Parameters,Type,District - _Delhi,District - Central,District - East,District - New Delhi,District - North,District - North East,District - North West,District - Shahdara,District - South,District - South East,District - South West,District - West
M1 [Ante Natal Care Services ANC],1.1,Total number of pregnant women Registered for ANC,TOTAL,331588,42512,17536,31033,31473,19323,37075,47769,14904,19538,14307,56118
M1 [Ante Natal Care Services ANC],1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,111448,13518,4887,7092,8697,7141,14731,10060,5814,9252,7050,23206
M1 [Ante Natal Care Services ANC],1.2,Number of Pregnant women registered under JSY,TOTAL,9324,1544,345,535,589,401,1363,974,201,576,746,2050
M1 [Ante Natal Care Services ANC],1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,183640,26441,7983,18325,15205,11960,27808,19218,8125,9905,9354,29316
M1 [Ante Natal Care Services ANC],1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,106876,11949,5854,9561,9688,7528,13896,12144,5702,8192,7214,15148
M1 [Ante Natal Care Services ANC],1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,92031,10672,5570,6732,8956,6940,11919,10215,5224,7240,6608,11955
M1 [Ante Natal Care Services ANC],1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,178505,18571,7179,19557,18388,9954,25229,17667,7222,8092,9267,37379
M1 [Ante Natal Care Services ANC],1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,6841,402,153,764,378,182,985,455,542,161,919,1900
M1 [Ante Natal Care Services ANC],1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,432,149,3,76,17,5,50,38,8,5,11,70
M1 [Ante Natal Care Services ANC],1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,102290,11676,4931,13285,9807,6923,18790,8543,2953,6265,8442,10675
M1 [Ante Natal Care Services ANC],1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,5194,253,141,496,411,127,988,851,113,111,773,930
M1 [Ante Natal Care Services ANC],1.8,Number of pregnancy test kits used at SC level,TOTAL,8129,335,341,707,368,760,262,443,2352,1972,144,445
M2 [Deliveries],2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,385,0,59,4,1,0,7,0,138,158,0,18
M2 [Deliveries],2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,4744,292,191,133,969,810,456,181,410,405,283,614
M2 [Deliveries],2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,5129,292,250,137,970,810,463,181,548,563,283,632
M2 [Deliveries],2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2640,233,143,82,503,268,96,142,276,291,170,436
M2 [Deliveries],2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,28,4,0,11,0,1,1,0,3,2,6,0
M2 [Deliveries],2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,63617,10177,2621,13322,2269,1884,10016,10322,1712,1214,2964,7116
M2 [Deliveries],2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,29049,5406,1438,9142,879,1479,1133,1430,1070,695,2102,4275
M2 [Deliveries],2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3760,602,195,309,475,39,688,299,94,124,481,454
M2 [Deliveries],2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1243,263,194,140,1,9,20,16,100,81,325,94
M2 [Deliveries],2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M2 [Deliveries],2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,12880,2649,1035,66,283,61,2260,964,1387,1492,633,2050
M2 [Deliveries],2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M2 [Deliveries],2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M2 [Deliveries],2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,9,0,NA,9,NA,0,0,NA,NA,0,NA,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,14775,2678,535,3434,150,220,2328,2217,571,170,565,1907
M3 [Number of Caesarean C-Section deliveries performed at],3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M3 [Number of Caesarean C-Section deliveries performed at],3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,14784,2678,535,3443,150,220,2328,2217,571,170,565,1907
M3 [Number of Caesarean C-Section deliveries performed at],3.2,No. of C-section deliveries performed at Private facilities,TOTAL,7669,1616,661,35,81,40,1491,602,650,799,395,1299
M4 [Pregnancy outcome & weight of new-born],4.1.1.a,Number of male live births,TOTAL,42882,6931,2089,6999,1802,1379,6657,6125,1952,1717,2079,5152
M4 [Pregnancy outcome & weight of new-born],4.1.1.b,Number of female live births,TOTAL,38109,6096,1770,6354,1683,1364,5979,5234,1709,1584,1784,4552
M4 [Pregnancy outcome & weight of new-born],4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,80991,13027,3859,13353,3485,2743,12636,11359,3661,3301,3863,9704
M4 [Pregnancy outcome & weight of new-born],4.1.2,Number of still births,TOTAL,1481,293,65,340,49,17,273,190,49,20,28,157
M4 [Pregnancy outcome & weight of new-born],4.1.3,Number of Abortions (spontaneous or induced),TOTAL,13171,2173,1302,1105,753,187,1817,1210,989,875,667,2093
M4 [Pregnancy outcome & weight of new-born],4.2.1,Number of Newborns weighed at birth,TOTAL,77372,12770,3754,12744,3220,2344,12309,11299,3483,2941,3801,8707
M4 [Pregnancy outcome & weight of new-born],4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,17030,3048,764,1866,546,460,2871,3540,562,328,598,2447
M4 [Pregnancy outcome & weight of new-born],4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,59629,8962,2254,10753,2973,2179,9114,9252,2660,2147,2912,6423
M5 [Complicated pregnanices],5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6,0,0,0,0,NA,0,0,6,0,0,0
M5 [Complicated pregnanices],5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,219,0,6,0,8,67,11,74,NA,53,NA,0
M5 [Complicated pregnanices],5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,21918,5338,1061,3156,1800,104,2428,3387,1531,228,630,2255
M5 [Complicated pregnanices],5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M5 [Complicated pregnanices],5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,22143,5338,1067,3156,1808,171,2439,3461,1537,281,630,2255
M5 [Complicated pregnanices],5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,2711,461,74,0,109,41,321,376,537,534,118,140
M5 [Complicated pregnanices],5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,16997,4003,1133,1811,362,157,2291,2784,1053,772,617,2014
M5 [Complicated pregnanices],5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1884,180,5,320,89,95,114,351,60,64,59,547
M5 [Complicated pregnanices],5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,15665,5086,879,1476,457,172,2212,1785,1233,762,372,1231
M5 [Complicated pregnanices],5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,5612,479,595,868,173,19,1135,868,118,57,134,1166
M6 [Post - Natal Care],6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,70670,10807,3059,12855,3200,2369,11666,8830,3267,2861,3671,8085
M6 [Post - Natal Care],6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,50458,6595,2258,4753,2890,1858,7791,5489,1375,2575,4928,9946
M6 [Post - Natal Care],6.3,PNC maternal complications attended,TOTAL,2281,119,483,206,89,0,579,209,26,169,117,284
M7 [Medical Termination of Pregnancy (MTP)],7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2384,447,32,309,94,19,432,219,233,110,113,376
M7 [Medical Termination of Pregnancy (MTP)],7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,346,36,5,103,4,0,27,55,89,0,5,22
M7 [Medical Termination of Pregnancy (MTP)],7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2730,483,37,412,98,19,459,274,322,110,118,398
M7 [Medical Termination of Pregnancy (MTP)],7.2,Number of MTPs conducted at Private Facilities,TOTAL,4581,707,839,43,111,9,670,377,301,570,251,703
M8 [RTI/STI Cases],8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,11325,1760,535,2279,704,423,967,368,846,1090,860,1493
M8 [RTI/STI Cases],8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,57921,7235,3865,8793,3733,4267,5405,3773,2055,3169,3306,12320
M8 [RTI/STI Cases],8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,69246,8995,4400,11072,4437,4690,6372,4141,2901,4259,4166,13813
M8 [RTI/STI Cases],8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,194,0,2,0,0,0,0,0,9,14,6,163
M9 [Family Planning],9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,NA,NA,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,594,364,8,77,4,6,14,12,5,0,71,33
M9 [Family Planning],9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,594,364,8,77,4,6,14,12,5,0,71,33
M9 [Family Planning],9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,19,18,0,0,0,NA,0,0,1,0,0,0
M9 [Family Planning],9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,NA,0,0,0,0,0,0
M9 [Family Planning],9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,NA,NA,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,2153,637,7,379,32,11,291,138,229,26,107,296
M9 [Family Planning],9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,2153,637,7,379,32,11,291,138,229,26,107,296
M9 [Family Planning],9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,733,18,21,53,4,NA,385,142,6,79,2,23
M9 [Family Planning],9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,NA,0,0,0,0,0,0
M9 [Family Planning],9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0,0,NA,NA,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,678,81,39,295,17,2,77,59,21,1,45,41
M9 [Family Planning],9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,678,81,39,295,17,2,77,59,21,1,45,41
M9 [Family Planning],9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,49,10,6,0,0,NA,5,0,10,8,0,10
M9 [Family Planning],9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,NA,0,0,0,0,0,0
M9 [Family Planning],9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,5,0,NA,5,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1485,151,0,204,13,11,462,298,54,13,40,239
M9 [Family Planning],9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1490,151,0,209,13,11,462,298,54,13,40,239
M9 [Family Planning],9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,116,26,1,0,1,NA,10,3,5,26,2,42
M9 [Family Planning],9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,5,5,0,0,0,0,0,0,0,NA,0,0
M9 [Family Planning],9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,9264,1523,640,544,521,847,780,519,761,857,1018,1254
M9 [Family Planning],9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2809,311,221,173,269,452,279,273,NA,329,56,446
M9 [Family Planning],9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,17239,2617,1070,2486,1249,498,3036,1976,666,330,631,2680
M9 [Family Planning],9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,29317,4456,1931,3203,2039,1797,4095,2768,1427,1516,1705,4380
M9 [Family Planning],9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,14576,2138,1062,2043,1007,588,2530,1637,364,312,438,2457
M9 [Family Planning],9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,1338,201,90,65,98,11,208,142,84,172,70,197
M9 [Family Planning],9.06,Number of IUCD removals,TOTAL,4738,620,316,426,315,310,573,387,303,373,416,699
M9 [Family Planning],9.07,Number of Oral Pills cycles distributed,TOTAL,66919,7642,4908,5384,6392,5018,7988,6251,4158,7327,4461,7390
M9 [Family Planning],9.08,Number of Condom pieces distributed,TOTAL,2496279,290896,91625,171214,247457,151978,393646,155664,232100,275495,195544,290660
M9 [Family Planning],9.09,Number of Centchroman (weekly) pills given,TOTAL,68,36,0,0,0,0,0,0,21,0,0,11
M9 [Family Planning],9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,5166,414,565,285,633,327,632,424,634,460,168,624
M9 [Family Planning],9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.11.1.b,Number of cases of complications following female sterilization,TOTAL,6,0,0,0,0,0,0,5,0,0,0,1
M9 [Family Planning],9.11.2.a,Number of failures following male sterilization,TOTAL,1,0,0,0,0,0,0,0,0,0,0,1
M9 [Family Planning],9.11.2.b,Number of failures following female sterilization,TOTAL,20,4,0,3,1,0,4,5,0,0,0,3
M9 [Family Planning],9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.12,Number of Institutions having NSV trained doctors,TOTAL,222,22,16,32,14,1,52,31,17,12,9,16
M10 [CHILD IMMUNIZATION],10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,92068,12582,4915,14385,5349,4265,13379,12112,4176,5092,4553,11260
M10 [CHILD IMMUNIZATION],10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,5558,831,306,66,212,220,910,315,573,985,147,993
M10 [CHILD IMMUNIZATION],10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4957,755,289,75,179,185,622,252,554,948,151,947
M10 [CHILD IMMUNIZATION],10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4809,802,269,74,182,203,624,252,462,892,176,873
M10 [CHILD IMMUNIZATION],10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,88615,8677,5799,4991,8370,9013,11466,8014,5313,8435,6820,11717
M10 [CHILD IMMUNIZATION],10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,95099,8941,6915,4948,9133,9432,12554,8199,5995,8944,7343,12695
M10 [CHILD IMMUNIZATION],10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,97639,9296,6753,5008,9560,9528,12857,8451,6104,9000,7729,13353
M10 [CHILD IMMUNIZATION],10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,72155,11076,3656,12860,2768,2279,10735,10723,3029,2648,3446,8935
M10 [CHILD IMMUNIZATION],10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,91642,9436,6206,4902,8396,9028,11730,8299,4947,9159,6939,12600
M10 [CHILD IMMUNIZATION],10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,97759,9709,7101,4845,9107,9520,12613,8406,5746,9676,7491,13545
M10 [CHILD IMMUNIZATION],10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,100612,10049,7114,4971,9506,9591,12894,8586,5967,9860,7909,14165
M10 [CHILD IMMUNIZATION],10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,68898,10180,3563,12760,2714,1983,10812,10664,2618,2574,3366,7664
M10 [CHILD IMMUNIZATION],10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,6120,1052,506,48,62,671,716,495,374,786,217,1193
M10 [CHILD IMMUNIZATION],10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,4197,714,405,68,61,74,631,267,418,716,149,694
M10 [CHILD IMMUNIZATION],10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4055,852,369,78,77,86,509,229,420,653,184,598
M10 [CHILD IMMUNIZATION],10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,107647,10275,7553,5497,10287,10427,13765,8825,6880,10958,8211,14969
M10 [CHILD IMMUNIZATION],10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6020,745,417,247,477,1190,891,386,407,542,303,415
M10 [CHILD IMMUNIZATION],10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,55670,5237,3938,2916,5407,5312,7148,4436,3501,5426,4416,7933
M10 [CHILD IMMUNIZATION],10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,48140,4537,3453,2399,4587,4702,6349,3893,3100,4678,3685,6757
M10 [CHILD IMMUNIZATION],10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,103810,9774,7391,5315,9994,10014,13497,8329,6601,10104,8101,14690
M10 [CHILD IMMUNIZATION],10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,113057,10406,8325,5681,10910,11001,14665,9274,7344,9979,9193,16279
M10 [CHILD IMMUNIZATION],10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,111783,10373,8298,5676,10800,10954,14277,9003,7430,9843,9189,15940
M10 [CHILD IMMUNIZATION],10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,119663,11102,9028,6390,11362,9623,15311,11178,7905,12126,9479,16159
M10 [CHILD IMMUNIZATION],10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,16586,1693,523,1016,1882,1969,2346,1540,930,488,943,3256
M10 [CHILD IMMUNIZATION],10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,14032,1440,455,771,1511,1842,2061,1194,835,484,775,2664
M10 [CHILD IMMUNIZATION],10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,30618,3133,978,1787,3393,3811,4407,2734,1765,972,1718,5920
M10 [CHILD IMMUNIZATION],10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,51498,5581,4126,2825,4445,3778,6204,4167,3629,4830,4477,7436
M10 [CHILD IMMUNIZATION],10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,16267,1884,1330,1339,1087,1328,1789,1218,1392,1685,1300,1915
M10 [CHILD IMMUNIZATION],10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,10276,1552,773,868,924,707,1170,1032,708,915,934,693
M10 [CHILD IMMUNIZATION],10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4,0,2,0,0,0,2,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,11,4,0,0,0,0,2,1,1,3,0,0
M10 [CHILD IMMUNIZATION],10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,41486,5289,3319,2225,4159,3058,5848,2750,2448,4057,2573,5760
M10 [CHILD IMMUNIZATION],10.4.2,Number of Immunisation sessions held during the month,TOTAL,40349,5159,3238,2079,4019,3024,5696,2686,2407,3950,2484,5607
M10 [CHILD IMMUNIZATION],10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,21739,1088,2114,941,2135,2370,2850,1345,1272,2523,1941,3160
M10 [CHILD IMMUNIZATION],10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M11 [Number of Vitamin A doses],11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,58843,3030,7175,1412,3247,7768,4238,4956,4758,5980,7341,8938
M11 [Number of Vitamin A doses],11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,42426,1535,6787,671,4682,4365,3555,2882,2479,3961,3369,8140
M11 [Number of Vitamin A doses],11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,18434,582,3212,299,1665,2371,1528,1480,1035,2060,1420,2782
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,1,0,0,1,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,2,0,0,2,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,3,0,0,3,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,444,34,45,57,38,10,59,97,61,24,4,15
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,44254,3159,3745,4449,13716,712,4509,2312,1480,2519,963,6690
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,377,50,33,87,104,0,54,8,9,14,12,6
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,7151,489,677,1762,350,0,600,300,733,224,121,1895
M13 [Blindness Control Programme],13.1,Number of Patients operated for cataract,TOTAL,18956,9287,386,2516,273,174,1823,703,246,983,54,2511
M13 [Blindness Control Programme],13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,17954,9179,176,2495,185,174,1533,508,241,924,30,2509
M13 [Blindness Control Programme],13.3,Number of School children detected with Refractive errors,TOTAL,7816,365,106,0,609,215,1192,1010,943,306,368,2702
M13 [Blindness Control Programme],13.4,Number of children provided free glasses,TOTAL,984,0,0,0,0,0,304,0,0,0,0,680
M13 [Blindness Control Programme],13.5,Number of eyes collected through eye donation,TOTAL,604,517,0,30,0,0,0,0,0,0,0,57
M13 [Blindness Control Programme],13.6,Number of eyes utilised for corneal transplant,TOTAL,368,301,0,10,0,0,0,0,0,0,0,57
M14 [Patient Services],14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,154,21,9,16,12,15,35,21,3,2,4,16
M14 [Patient Services],14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA
M14 [Patient Services],14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1350,22,17,0,0,0,890,0,156,208,17,40
M14 [Patient Services],14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,134,16,14,4,12,16,24,20,NA,4,8,16
M14 [Patient Services],14.05,Number of RKS meetings held during the month,TOTAL,23,2,0,0,1,5,8,1,0,1,2,3
M14 [Patient Services],14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,721,54,143,107,21,16,87,44,39,44,112,54
M14 [Patient Services],14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,16582,1025,1992,5193,382,456,1844,1030,507,771,918,2464
M14 [Patient Services],14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,238,36,20,19,12,1,40,28,30,20,12,20
M14 [Patient Services],14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,678,124,59,127,9,0,207,25,18,46,11,52
M14 [Patient Services],14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,91938,16873,7014,22979,3139,1127,14973,8360,2677,4603,3182,7011
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,191943,55332,10308,27679,2302,1278,30688,19482,6577,13274,5685,19338
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,70237,11565,4567,20349,2389,963,11203,6254,1982,2882,2712,5371
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,266222,59274,15986,37782,5901,3815,44264,34250,9228,14758,10182,30782
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,162175,28438,11581,43328,5528,2090,26176,14614,4659,7485,5894,12382
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,458165,114606,26294,65461,8203,5093,74952,53732,15805,28032,15867,50120
M14 [Patient Services],14.10.2.a,Number of death cases of Inpatient males,TOTAL,8206,2889,651,1674,165,7,1247,405,135,195,69,769
M14 [Patient Services],14.10.2.b,Number of death cases of Inpatient females,TOTAL,4954,1551,398,1000,60,10,799,318,100,119,39,560
M14 [Patient Services],14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13160,4440,1049,2674,225,17,2046,723,235,314,108,1329
M14 [Patient Services],14.11,In-Patient Head Count at midnight,TOTAL,1632670,299509,114336,442880,48003,14655,230427,111831,66157,104466,30450,169956
M14 [Patient Services],14.12.1,OPD attendance (All),TOTAL,20579946,2921886,1199235,3163956,1226877,958314,2752272,2174814,907904,1205581,1362410,2706697
M14 [Patient Services],14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,114729,27480,7931,20410,1336,873,15610,6131,6999,10304,2163,15492
M14 [Patient Services],14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2710,499,266,315,107,11,571,172,194,249,198,128
M14 [Patient Services],14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,0,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA
M14 [Patient Services],14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,210888,17914,13072,34218,10378,5364,37514,9012,1864,6939,2168,72445
M14 [Patient Services],14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,0,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA
M14 [Patient Services],14.14.a,Number of patients given AYUSH treatment,TOTAL,669294,109788,76211,75015,62802,1678,64675,84108,14235,67533,32448,80801
M14 [Patient Services],14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,204401,50772,5128,52281,11280,758,24188,6464,3925,11322,11304,26979
M14 [Patient Services],14.14.c,Number of Adolescents counselled,TOTAL,24498,5529,1643,1618,2784,1308,4572,840,158,1005,2637,2404
M15 [Laboratory Testing],15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,510957,492580,NA,NA,NA,NA,NA,18377,NA,NA,NA,NA
M15 [Laboratory Testing],15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1954873,730224,106164,251334,48384,24969,195937,150633,126240,56322,76252,188414
M15 [Laboratory Testing],15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,45952,8128,2578,4791,1783,1328,5636,6200,1420,775,1840,11473
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,1. Number tested,109978,19417,10363,28054,3480,2719,14530,7128,10214,1656,3104,9313
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1262,127,62,423,35,46,252,98,56,11,27,125
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,65247,8408,5270,10525,3306,2685,11447,5678,5678,1858,2606,7786
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,501,37,33,180,10,6,106,27,23,0,12,67
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,101181,15850,6623,10697,9141,8101,15759,8654,4783,3292,8990,9291
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,401,17,8,24,4,135,46,112,12,1,4,38
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,276406,43675,22256,49276,15927,13505,41736,21460,20675,6806,14700,26390
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2164,181,103,627,49,187,404,237,91,12,43,230
M15 [Laboratory Testing],15.2,Number of Widal tests conducted,Number tested,96690,8689,5805,10506,7901,2275,12360,8956,5674,4795,6472,23257
M15 [Laboratory Testing],15.3.a,Number of VDRL tests conducted on males,Number tested,20852,1762,5288,6311,885,125,759,1155,1783,626,421,1737
M15 [Laboratory Testing],15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,23091,1721,1271,8038,1220,1002,1621,581,862,860,802,5113
M15 [Laboratory Testing],15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,93660,9408,5324,11519,6546,5426,18802,7869,4432,3898,10303,10133
M15 [Laboratory Testing],15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,137603,12891,11883,25868,8651,6553,21182,9605,7077,5384,11526,16983
M15 [Laboratory Testing],15.4.1,Number of blood smears examined for Malaria,TOTAL,222303,8594,6719,9412,3376,1816,13627,10033,144247,3790,7603,13086
M15 [Laboratory Testing],15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1331,18,74,85,42,20,108,71,583,175,65,90
M15 [Laboratory Testing],15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,241,2,1,1,0,1,2,0,7,226,1,0
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,150860,6010,11130,20660,9610,11850,19040,5360,25150,13840,12340,15870
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,2. Stocks Received,172660,17000,11500,9000,14020,15000,22630,16070,12440,14000,17500,23500
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,3. Unusable Stock,20960,2560,0,0,0,0,18400,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,4. Stock Distributed,153987,16940,12960,8320,9370,16417,20330,13730,13090,14970,10260,17600
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,5. Total Stock,148573,3510,9670,21340,14260,10433,2940,7700,24500,12870,19580,21770
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,159830,4130,6140,17430,7280,24910,12780,8220,24090,23060,14870,16920
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,2. Stocks Received,262730,32400,16920,14400,15360,37540,36000,24480,15550,22320,15360,32400
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,12870,490,0,0,0,0,12380,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,235670,24270,17900,13610,15080,27560,34870,22760,14360,21950,14320,28990
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,5. Total Stock,174020,11770,5160,18220,7560,34890,1530,9940,25280,23430,15910,20330
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,260750,40280,20460,20580,4010,18240,9680,9140,27980,18320,23640,68420
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,2. Stocks Received,397360,55720,38040,30800,12000,40000,23080,34700,28000,31000,18000,86020
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,3. Unusable Stock,11020,1760,0,0,0,0,9260,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,4. Stock Distributed,406830,70160,37340,37640,10050,26580,23400,33680,25000,23940,26880,92160
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,5. Total Stock,240260,24080,21160,13740,5960,31660,100,10160,30980,25380,14760,62280
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,134655,2340,6600,21410,9620,12990,14230,8120,20410,15015,14170,9750
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,2. Stocks Received,205220,44500,11060,10000,12500,21490,26500,13000,12170,17000,20000,17000
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,3. Unusable Stock,12870,0,0,0,0,0,12870,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,4. Stock Distributed,169145,19650,11960,11110,10770,17070,23720,12460,10130,16475,17070,18730
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,5. Total Stock,157860,27190,5700,20300,11350,17410,4140,8660,22450,15540,17100,8020
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,137840,3590,8370,13080,10130,12810,17640,6590,28900,22400,7340,6990
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,2. Stocks Received,156760,17500,6000,18000,8000,14000,24500,17500,13260,13000,5000,20000
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,3. Unusable Stock,16790,1620,0,0,0,0,15170,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,4. Stock Distributed,133880,14270,7360,18740,7250,11590,20240,15120,7460,10430,4380,17040
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,5. Total Stock,143930,5200,7010,12340,10880,15220,6730,8970,34700,24970,7960,9950
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,129465,5315,7705,18360,6570,14480,12460,6050,21005,14350,14075,9095
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,2. Stocks Received,146280,16000,9690,6000,11500,17750,21000,10500,10840,14000,9000,20000
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,3. Unusable Stock,12500,1600,0,0,0,0,10900,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,4. Stock Distributed,130060,10825,10570,6225,10575,14820,21325,10870,8620,13180,7215,15835
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,5. Total Stock,133185,8890,6825,18135,7495,17410,1235,5680,23225,15170,15860,13260
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,64080,1280,9680,7100,2070,5070,8030,7210,5740,5380,5240,7280
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,60120,10210,1390,13000,2500,2000,9840,13000,680,500,1500,5500
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,7460,280,0,0,0,0,7180,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,50640,7720,1980,8430,1010,1600,8090,10500,2220,2140,1470,5480
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,66100,3490,9090,11670,3560,5470,2600,9710,4200,3740,5270,7300
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,17892,1076,1085,679,1806,1284,1170,2100,1454,2680,3270,1288
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,15983,1800,1433,800,3600,1150,600,2600,600,1200,1000,1200
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,1114,219,0,0,0,0,895,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,19631,1031,931,553,1704,523,850,10040,662,975,770,1592
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,13130,1626,1587,926,3702,1911,25,-5340,1392,2905,3500,896
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,1469590,23080,5500,15500,102430,83120,1172400,18620,27000,0,21940,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,1520390,84960,22300,97200,92430,43200,689400,59400,238000,193500,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,983640,8640,0,0,0,0,975000,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,1120550,71260,21160,15660,96570,68950,474000,52080,162400,139500,18970,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,885790,28140,6640,97040,98290,57370,412800,25940,102600,54000,2970,0
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,71147,4283,3317,4800,8500,9260,6297,5800,6000,9780,8735,4375
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,53771,5500,3471,2500,7200,3000,2000,5600,8000,8000,1500,7000
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,7013,3231,0,0,0,0,3782,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,39848,3699,2904,2020,3560,3370,4495,2500,5850,5620,2295,3535
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,78057,2853,3884,5280,12140,8890,20,8900,8150,12160,7940,7840
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,28617,311,885,845,5030,2420,10430,4150,340,265,2605,1336
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,12330,600,3225,600,1800,500,0,2000,1320,885,700,700
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,7171,61,0,0,0,0,7110,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,6425,341,1215,170,700,249,1852,350,530,335,280,403
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,27351,509,2895,1275,6130,2671,1468,5800,1130,815,3025,1633
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,994,NA,0,0,0,0,664,80,50,NA,0,200
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,1200,NA,0,400,0,0,NA,300,100,NA,200,200
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,664,NA,0,0,0,0,664,NA,0,NA,0,NA
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,960,NA,0,400,0,0,NA,260,100,NA,0,200
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,570,0,0,0,0,0,0,120,50,0,200,200
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,2,NA,0,NA,0,2,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,-2,0,0,0,0,-2,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,267000,60000,0,0,0,37000,150000,20000,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,2. Stocks Received,505000,30000,0,120000,120000,120000,10000,105000,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,30000,NA,0,0,0,0,30000,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,321450,79300,0,53850,63600,45500,3600,75600,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,5. Total Stock,420550,10700,0,66150,56400,111500,126400,49400,0,0,0,0
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,3000,NA,0,NA,0,3000,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,9500,NA,0,NA,0,9500,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,3500,NA,0,NA,0,3500,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,9000,0,0,0,0,9000,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1902,NA,583,3,1,144,177,106,160,94,575,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,4603,NA,200,100,200,493,2160,500,300,450,200,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,148,NA,0,0,0,0,148,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,2393,NA,489,100,116,303,237,283,138,270,398,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,5. Total Stock,3964,0,294,3,85,334,1952,323,322,274,377,0
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,24770,NA,0,4250,0,0,NA,14500,NA,NA,6020,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,81000,NA,0,10000,30200,0,40800,0,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,NA,0,0,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,79160,NA,0,6900,25200,0,38000,5500,NA,NA,3560,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,26610,0,0,7350,5000,0,2800,9000,0,0,2460,0
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,132994,9000,7654,6705,5150,14104,18600,8900,27380,13700,9671,12130
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,117050,8000,8160,16000,12000,4000,25000,12000,11090,10000,2000,8800
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,19000,800,0,0,0,0,18200,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,98590,8600,5790,14040,11850,5650,15200,11850,2200,8300,2890,12220
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,132454,7600,10024,8665,5300,12454,10200,9050,36270,15400,8781,8710
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,1234980,121600,14000,67600,191980,68600,106600,41000,246700,169000,87400,120500
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,1240800,146800,52700,39600,216000,93600,162400,82800,75300,139600,57600,174400
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,205000,101700,0,0,0,0,103300,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,852830,89400,50800,35400,94750,79100,133900,72600,50000,91400,58100,97380
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,1417950,77300,15900,71800,313230,83100,31800,51200,272000,217200,86900,197520
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,164554,16700,7040,2940,9500,10480,19300,5700,33760,42700,9764,6670
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,81030,13000,4500,2000,4000,2000,18500,9000,8530,4000,6000,9500
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,31700,12600,0,0,0,0,19100,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,53535,4620,3760,1030,4950,2600,8600,6200,2870,5300,6595,7010
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,160349,12480,7780,3910,8550,9880,10100,8500,39420,41400,9169,9160
M17 [Details of deaths reported during the month with probable causes:],17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,50,12,1,4,3,3,23,1,1,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,163,19,69,47,2,NA,16,1,NA,NA,2,7
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,38,3,12,15,3,NA,5,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,201,22,81,62,5,NA,21,1,NA,NA,2,7
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,133,15,42,53,4,NA,14,2,2,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,5,NA,1,3,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,138,15,43,56,4,NA,15,2,2,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,188,28,NA,48,3,NA,20,NA,NA,NA,2,87
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,10,2,NA,4,NA,NA,3,1,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,198,30,NA,52,3,NA,23,1,NA,NA,2,87
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,245,12,49,68,3,5,66,3,NA,2,4,33
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,18,1,6,3,1,1,6,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,263,13,55,71,4,6,72,3,NA,2,4,33
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,81,2,23,39,5,NA,7,1,1,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,26,NA,5,15,1,NA,2,2,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,107,2,28,54,6,NA,9,3,1,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,22,1,NA,12,1,NA,7,1,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,11,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,33,1,NA,22,1,NA,7,1,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,14,NA,NA,12,NA,1,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,19,NA,NA,17,1,NA,NA,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,33,NA,NA,29,1,1,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,214,9,59,88,8,3,28,9,6,NA,2,2
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,84,4,16,40,1,1,8,4,NA,NA,1,9
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,298,13,75,128,9,4,36,13,6,NA,3,11
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,1,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,44,16,1,11,1,NA,11,1,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,27,4,1,2,NA,NA,16,1,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,72,20,2,14,1,NA,27,2,NA,NA,NA,6
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,14,NA,NA,7,NA,NA,5,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,146,6,5,48,1,NA,51,5,1,NA,NA,29
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,102,5,3,43,2,NA,27,4,NA,1,3,14
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,262,11,8,98,3,NA,83,9,1,1,3,45
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,21,NA,NA,17,1,NA,NA,NA,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,250,24,19,70,9,NA,64,9,2,4,5,44
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,371,46,43,54,11,NA,109,12,1,5,13,77
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,642,70,62,141,21,NA,173,21,3,9,18,124
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,5,NA,1,2,NA,NA,2,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,5,NA,1,2,NA,NA,2,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,28,NA,NA,20,1,NA,5,1,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,82,8,2,22,4,NA,31,NA,NA,NA,1,14
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,54,4,1,7,2,NA,30,NA,NA,NA,1,9
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,164,12,3,49,7,NA,66,1,NA,NA,2,24
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,22,1,NA,2,NA,NA,7,1,NA,NA,NA,11
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,3,NA,NA,2,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,25,1,NA,4,NA,NA,8,1,NA,NA,NA,11
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,6,NA,NA,2,NA,NA,4,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,337,26,25,107,11,NA,73,17,6,4,15,53
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,636,67,49,168,15,NA,122,22,35,15,22,121
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,979,93,74,277,26,NA,199,39,41,19,37,174
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,9,NA,NA,5,1,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,137,15,8,10,3,NA,62,12,NA,NA,1,26
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,132,19,20,6,NA,NA,57,8,1,NA,11,10
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,278,34,28,21,4,NA,122,20,1,NA,12,36
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,2,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,2,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,18,4,NA,10,NA,NA,3,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,18,4,NA,10,NA,NA,3,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,7,NA,NA,4,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,7,NA,NA,4,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,12,2,1,9,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,12,2,1,9,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,105,16,2,24,3,NA,7,34,1,NA,NA,18
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,105,16,2,24,3,NA,7,34,1,NA,NA,18
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,10,NA,1,7,NA,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,298,10,19,142,43,NA,45,1,NA,NA,4,34
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,79,6,10,23,4,NA,18,NA,1,NA,4,13
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,387,16,30,172,47,NA,64,1,1,NA,8,48
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,30,NA,NA,NA,8,NA,13,1,NA,NA,7,1
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,4,NA,2,NA,NA,NA,1,NA,NA,NA,1,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,34,NA,2,NA,8,NA,14,1,NA,NA,8,1
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,5,NA,NA,1,1,NA,1,NA,NA,NA,1,1
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,6,NA,NA,1,1,NA,1,NA,NA,NA,1,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,54,1,26,25,NA,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,611,43,3,460,5,NA,60,2,NA,NA,1,37
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,426,62,3,289,1,NA,40,3,NA,NA,1,27
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1091,106,32,774,6,NA,101,5,NA,NA,2,65
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,20,1,6,13,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,517,80,23,205,6,NA,109,15,NA,NA,6,73
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,538,105,41,147,4,NA,128,22,NA,NA,14,77
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1075,186,70,365,10,NA,237,37,NA,NA,20,150
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,7,NA,3,1,1,NA,NA,1,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,445,4,165,54,62,NA,95,23,2,3,4,33
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,234,1,55,29,2,NA,74,23,17,6,19,8
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,686,5,223,84,65,NA,169,47,19,9,23,42
